parenterally administering a composition is provided, the method comprising parenterally administering to a person a composition containing EPA and/or DHA and/or DPA and/or ALA and/or AA and/or LA and/or OA and/or caprylic acid and/or capric acid to selectively treat severe hepatic steatosis...